Abstract
The involvement of microRNAs in human pathologies is a firmly established fact. Accordingly, the pharmacological modulation of their activity appears to be a very appealing issue in the development of new types of drugs (miRNA therapeutics). One of the most interesting issues is the possible development of miRNA therapeutics for development of anti-cancer molecules. In this respect appealing molecules are based on peptide nucleic acids (PNAs), displaying a pseudo-peptide backbone composed of N-(2-aminoethyl)glycine units and found to be excellent candidates for antisense and antigene therapies. The major limit in the use of PNAs for alteration of gene expression is the low uptake by eukaryotic cells. The aim of this chapter is to describe methods for determining the activity of PNAs designed to target oncomiRNAs, using as model system miR-221 and its target p27Kip1 mRNA. The effects of PNAs targeting miR-221 are here presented discussing data obtained using as model system the human breast cancer cell line MDA-MB-231, in which miR-221 is up-regulated and p27Kip1 down-regulated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AEEA:
-
2-(2-aminoethoxy)ethoxyacetyl spacer
- FACS:
-
Fluorescence-activated cell sorter
- FBS:
-
Fetal bovine serum
- Fl:
-
Fluorescein
- PBS:
-
Phosphate-buffered saline
- PNA:
-
Peptide nucleic acid
- 3′UTR:
-
3′-untranslated region
- RT-qPCR:
-
Retro transcription-quantitative polymerase chain reaction
- EDTA:
-
Ethylenediaminetetraacetic acid
- SDS:
-
Sodium dodecyl sulfate
- DTT:
-
Dithiotreithol
- TBS:
-
Tris-buffered saline
- HRP:
-
Horseradish peroxidase
- RISC:
-
RNA-induced silencing complex
References
He L, Hannon GJ (2010) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522–531
Manicardi A, Fabbri E, Tedeschi T, Sforza S, Bianchi N et al (2012) Cellular Uptakes, Biostabilities and Anti-miR-210 Activities of Chiral Arginine-PNAs in Leukaemic K562 Cells. Chembiochem 13:1327–1337
Fabbri E, Manicardi A, Tedeschi T, Sforza S, Bianchi N et al (2011) Modulation of the biological activity of microRNA-210 with peptide nucleic acids (PNAs). ChemMedChem 6:2192–2202
Fabbri E, Brognara E, Borgatti M, Lampronti I, Finotti A et al (2011) miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs. Epigenomics 3:733–745
Gambari R, Fabbri E, Borgatti M, Lampronti I, Finotti A et al (2011) Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development. Biochem Pharmacol 82:1416–1429
Nielsen PE, Egholm M, Berg RH, Buchardt O (1991) Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254:1497–1500
Nastruzzi C, Cortesi R, Esposito E, Gambari R, Borgatti M et al (2000) Liposomes as carriers for DNA-PNA hybrids. J Control Release 68:237–249
Karkare S, Bhatnagar D (2006) Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino. Appl Microbiol Biotechnol 71:575–586
Tonelli R, Fronza S, Purgato S, Camerin C, Bologna F et al (2005) Anti-gene Peptide Nucleic Acid (PNA) Specifically Inhibits N-myc Expression in Human Neuroblastoma Cells Leading to Persistent Cell-growth Inhibition and Apoptosis. Mol Cancer Ther 4:779–786
Nielsen PE (2001) Targeting double stranded DNA with peptide nucleic acid (PNA). Curr Med Chem 8:545–550
Borgatti M, Lampronti I, Romanelli A, Pedone C, Saviano M et al (2003) Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites. J Biol Chem 278:7500–7509
Rasmussen FW, Bendifallah N, Zachar V, Shiraishi T, Fink T et al (2006) Evaluation of transfection protocols for unmodified and modified peptide nucleic acid (PNA) oligomers. Oligonucleotides 16:43–57
Cortesi R, Mischiati C, Borgatti M, Breda L, Romanelli A et al (2004) Formulations for natural and peptide nucleic acids based on cationic polymeric submicron particles. AAPS Pharmsci 6:10–21
Borgatti M, Breda L, Cortesi R, Nastruzzi C, Romanelli A et al (2002) Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappaB transcription factors. Biochem Pharmacol 64:609–616
Abes R, Arzumanov A, Moulton H, Abes S, Ivanova G (2008) Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides. J Pept Sci 14:455–460
Torres AG, Threlfall RN, Gait MJ (2011) Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2′-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents. Artificial DNA PNA XNA 3:71–78
Zhang C, Kang C, You Y, Pu P, Yang W (2009) Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. Int J Oncol 34:1653–1660
Le Sage C, Nagel R, Egan DA, Schrier M, Mesman E (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26:3699–3708
Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafrè SA, Farace MG (2007) miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282:2316–2324
Mizuma M, Katayose Y, Yamamoto K, Shiraso S, Sasaki T (2008) Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells. Anticancer Res 28:2669–2677
Bianchi N, Zuccato C, Lampronti I, Borgatti M, Gambari R (2009) Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression. BMB Rep 42:493–499
Brognara E, Fabbri E, Aimi F, Manicardi A, Bianchi N et al (2012) Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells. Int J Oncol 41:2119–2127. doi:10.3892
Acknowledgments
This work was partially supported by a grant from MIUR (PRIN09 grant n. 20093N774P “Molecular recognition of microRNA (miR) by modified PNA: from structure to activity”). R.G. is granted by Fondazione Cariparo (Cassa di Risparmio di Padova e Rovigo), by UE ITHANET Project (Infrastructure for the Thalassaemia Research Network), by Telethon (contract GGP10214). This research is also supported by CIB (Interuniversity Consortium for Biotechnologies) and by Associazione Veneta per la Lotta alla Talassemia (AVLT), Rovigo.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Brognara, E., Fabbri, E., Bianchi, N., Finotti, A., Corradini, R., Gambari, R. (2014). Molecular Methods for Validation of the Biological Activity of Peptide Nucleic Acids Targeting MicroRNAs. In: Arenz, C. (eds) miRNA Maturation. Methods in Molecular Biology, vol 1095. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-703-7_14
Download citation
DOI: https://doi.org/10.1007/978-1-62703-703-7_14
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-702-0
Online ISBN: 978-1-62703-703-7
eBook Packages: Springer Protocols